Elutia Inc (ELUT)
Elutia to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025
Corcept Therapeutics Incorporated (CORT)
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
Illumina Inc (ILMN)
Illumina, Inc. - Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025
OPKO HEALTH (OPK)
OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results
STRAWBERRY FIELDS REIT,INC (STRW)
GeneDx Holdings (WGSWW)
Orchestra Biomed Holdings Inc (OBIO)
New Form 8-K - Orchestra BioMed Holdings, Inc. Filed: 2025-07-31 AccNo: 0001104659-25-072678 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item …
DarioHealth Corp (DRIO)
Sangamo Therapeutics Inc (SGMO)
Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call
Tandem Diabetes Care Inc (TNDM)
Tandem Diabetes Care Announces Upcoming Conference Participation
Bionano Genomics Inc (BNGO)
Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025
Conduit Pharmaceuticals Inc (CDT)
ResMed Inc (RMD)
New SEC Form for ResMed Inc.